Research Analysts’ Updated EPS Estimates for November, 14th (BAB, BAYN, BOK, BTU, CHG, CJ, CVRR, DB, DK, ECM)

Research Analysts’ updated eps estimates for Tuesday, November 14th:

Babcock International Group plc (LON:BAB) had its buy rating reiterated by analysts at Peel Hunt. They currently have a GBX 1,085 ($14.27) price target on the stock.

Bayer AG (FRA:BAYN) had its buy rating reaffirmed by analysts at DZ Bank AG.

Booker Group PLC (LON:BOK) had its buy rating reaffirmed by analysts at Peel Hunt. Peel Hunt currently has a GBX 225 ($2.96) target price on the stock.

Jefferies Group LLC assumed coverage on shares of Peabody Energy Corporation (NYSE:BTU). They issued a buy rating and a $38.00 price target on the stock.

Chemring Group plc (LON:CHG) had its add rating reissued by analysts at Peel Hunt. Peel Hunt currently has a GBX 185 ($2.43) target price on the stock.

C&J Energy Services (NYSE:CJ) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.

CVR Refining, (NYSE:CVRR) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating.

Deutsche Bank AG (NYSE:DB) was upgraded by analysts at HSBC Holdings plc from a hold rating to a buy rating.

Delek US Holdings (NYSE:DK) was upgraded by analysts at Wells Fargo & Company from a market perform rating to an outperform rating.

Electrocomponents plc (LON:ECM) had its reduce rating reiterated by analysts at Peel Hunt. The firm currently has a GBX 650 ($8.55) target price on the stock.

Amryt Pharma PLC (LON:FAST) had its speculative buy rating reiterated by analysts at Beaufort Securities. Beaufort Securities currently has a GBX 65 ($0.85) price target on the stock.

Games Workshop Group PLC (LON:GAW) had its buy rating reiterated by analysts at Peel Hunt. They currently have a GBX 2,400 ($31.57) price target on the stock.

Genedrive PLC (LON:GDR) had its buy rating reissued by analysts at Peel Hunt. Peel Hunt currently has a GBX 150 ($1.97) price target on the stock.

General Electric (NYSE:GE) had its buy rating reissued by analysts at Citigroup Inc..

Helical plc (LON:HLCL) had its add rating reissued by analysts at Peel Hunt. The firm currently has a GBX 350 ($4.60) price target on the stock.

Jounce Therapeutics (NYSE:JNCE) had its buy rating reiterated by analysts at J P Morgan Chase & Co. The analysts wrote, “Though JNCE’s 3Q earnings call this morning was largely uneventful, we had a chance to catch up with management afterwards for some color around plans for the dissemination of initial JTX-2011 efficacy data. Recall that the Phase 1/2 ICONIC trial is expected to produce preliminary efficacy data in 1H18 (monotherapy began dosing in April and combo therapy began dosing in July). Per management, it is unlikely that we will see actual data until a full presentation at ASCO, though we may receive some guidance in regards to tumor types and enrollment in advance of that. The bottom line is that we see JNCE as an intriguing emerging player in immuno- oncology given the promising mechanism of action and preclinical data generated by its lead asset and a management team with considerable experience in the space. Maintain OW.””

Kier Group plc (LON:KIE) had its buy rating reaffirmed by analysts at Peel Hunt. Peel Hunt currently has a GBX 1,600 ($21.04) target price on the stock.

Coca-Cola Company (The) (NYSE:KO) was upgraded by analysts at Wells Fargo & Company from a market perform rating to an outperform rating.

Marcus & Millichap (NYSE:MMI) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating.

Marathon Petroleum Corporation (NYSE:MPC) had its buy rating reaffirmed by analysts at Cowen and Company.

Merck KGaA (FRA:MRK) had its neutral rating reiterated by analysts at DZ Bank AG.

Mitie Group PLC (LON:MTO) had its hold rating reaffirmed by analysts at Peel Hunt. The firm currently has a GBX 253 ($3.33) target price on the stock.

Barclays PLC assumed coverage on shares of Navient (NYSE:NAVI). The firm issued an overweight rating on the stock.

OpGen (NASDAQ:OPGN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $0.25 price target on the stock. According to Zacks, “OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. “

Otonomy (NASDAQ:OTIC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $5.75 target price on the stock. According to Zacks, “Otonomy, Inc. engages in developing and commercializing therapeutics to address unmet medical needs in the otology market. It develops therapeutics for treatment of inner and middle ear disorders. The Company’s product candidates under development includes AuriPro to treat pediatric patients with middle ear effusion; and OTO-104 for the treatment of patients with Ménière’s disease. Otonomy, Inc. is headquartered in San Diego, California. “

Oxford Instruments plc (LON:OXIG) had its hold rating reiterated by analysts at Peel Hunt. They currently have a GBX 1,020 ($13.42) target price on the stock.

PBF Energy (NYSE:PBF) was upgraded by analysts at Barclays PLC from an underweight rating to an overweight rating.

PTC (NASDAQ:PMTC) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $69.00 price target on the stock.

QUALCOMM (NYSE:QCOM) had its buy rating reaffirmed by analysts at Royal Bank Of Canada.

Macquarie assumed coverage on shares of Qudian Inc. Sponsored ADR (NYSE:QD). They issued an outperform rating on the stock.

Regional REIT (LON:RGL) had its buy rating reaffirmed by analysts at Peel Hunt. Peel Hunt currently has a GBX 125 ($1.64) price target on the stock.

RPC Group Plc (LON:RPC) had its buy rating reaffirmed by analysts at Peel Hunt. They currently have a GBX 1,250 ($16.44) price target on the stock.

B. Riley started coverage on shares of Sucampo Pharmaceuticals (NASDAQ:SCMP). The firm issued a buy rating and a $14.00 target price on the stock.

SDL plc (LON:SDL) had its buy rating reissued by analysts at Peel Hunt. The firm currently has a GBX 610 ($8.02) target price on the stock.

Serco Group plc (LON:SRP) had its hold rating reiterated by analysts at Peel Hunt. They currently have a GBX 123 ($1.62) price target on the stock.

Tharisa Plc (LON:THS) had its buy rating reiterated by analysts at Peel Hunt. They currently have a GBX 200 ($2.63) price target on the stock.

Vesuvius Plc (LON:VSVS) had its buy rating reaffirmed by analysts at Peel Hunt. The firm currently has a GBX 740 ($9.73) price target on the stock.

Macquarie began coverage on shares of Yirendai (NYSE:YRD). Macquarie issued an outperform rating on the stock.

Zimmer Biomet Holdings (NYSE:ZBH) was upgraded by analysts at Deutsche Bank AG from a hold rating to a buy rating. The firm currently has $128.00 target price on the stock.

Zpg Plc (LON:ZPLA) had its buy rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a GBX 542 ($7.13) price target on the stock.

Receive News & Ratings for Babcock International Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Babcock International Group plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply